Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/AMGN
icon
Up to 4x
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Amgen, Inc. (AMGN) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Amgen (AMGN) declined 10.08% to $393.17 following negative clinical trial news from competitor Novartis, creating pressure on the cholesterol drug class. Despite the selloff, the company maintains strong fundamentals with Q2 2026 EPS of $6.29 beating expectations by 12% and robust profitability metrics including 69.52% gross margins. Technical indicators show oversold conditions with RSI readings below 24, while the stock trades near key support at $386 with a bearish technical signal overall.
The long-term outlook remains supported by solid earnings growth and a 55% analyst buy rating, though near-term volatility from drug development setbacks presents headwinds. With a consensus price target of $398.52 offering 1.4% upside, investors face balancing strong fundamentals against sector-specific clinical trial risks and high debt levels of $56.55 billion.
Read full analysis

Key Stats

  • Market Cap
    $211.53B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $444.12
  • 52W Low
    $271.18
  • Typical Hold Time
    -
  • Enterprise Value
    $254.85B
  • Div Yield
    2.58%
  • Trading Activity
    -
$391.45
52W Low: $271.18
25 Sep 2025
52W High: $444.12
03 Sep 2026

Track Amgen, Inc. (AMGN) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Amgen, Inc. has traded between a low of $271.18 and a high of $444.12, highlighting its annual price range. Buy and sell Amgen, Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Amgen, Inc.

Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).

Most Recent News

Content is generated by Aura AI

This tax-efficient ETF yields 12% with most monthly payouts potentially avoiding current taxes.

The NEOS S&P 500 High Income ETF (SPYI) offers a 12.04% distribution rate, largely composed of return of capital (ROC), which defers taxes until shares are sold. This ETF combines S&P 500 exposure with a call spread strategy to generate monthly incom...

Market News
4 hours ago
24/7 Wall Street
Bullish
news icon
This tax-efficient ETF yields 12% with most monthly payouts potentially avoiding current taxes.

Ryanair warns airfare hikes likely if oil prices stay high through winter months

Ryanair CEO Michael O'Leary warned that airfare prices from December to March could rise significantly if oil prices remain elevated, due to the high cost of jet fuel impacting the airline industry. While prices are expected to be slightly lower in t...

Market News
4 hours ago
CNBC
Bearish
news icon
Ryanair warns airfare hikes likely if oil prices stay high through winter months

Invesco Global Clean Energy ETF (PBD) offers global exposure and lower risk than US-focused PBW ETF.

The Invesco Global Clean Energy ETF (PBD) tracks the WilderHill NEX Index, providing investors with global clean energy exposure compared to the more US-centric PBW ETF. PBD's broader international diversification results in lower short- and medium-t...

Market News
4 hours ago
Seeking Alpha
Bullish
news icon
Invesco Global Clean Energy ETF (PBD) offers global exposure and lower risk than US-focused PBW ETF.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $211.53B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $444.12
  • 52W Low
    $271.18
  • Typical Hold Time
    -
  • Enterprise Value
    $254.85B
  • Div Yield
    2.58%
  • Trading Activity
    -
$391.45
52W Low: $271.18
25 Sep 2025
52W High: $444.12
03 Sep 2026

Track Amgen, Inc. (AMGN) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Amgen, Inc. has traded between a low of $271.18 and a high of $444.12, highlighting its annual price range. Buy and sell Amgen, Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!